Webinars
Reducing Clinician and Patient Biases against Vaginal Insert Therapies
Dates this webinar will be offered:
This is an internet-based activity that should take 1 hour to complete.
To participate in this live webinar learners should:
- Take the pretest
- Listen to webinar
- Take the post-test
- Complete follow-up evaluation survey
Learning Objectives
At the conclusion of this presentation, participants should be able to:
- Explain the potential benefits, uses, indications, efficacy, and adverse effects of currently available vaginal insert therapies
- Use evidence-based resources to effectively dispel patient fears and misconceptions about the vagina, female anatomy, and vaginal insert therapies from adolescence, menopause and beyond.
- Apply appropriate patient-centered communication skills to conversations about vaginal bias
Accreditation Information
Physicians: ACCREDITATION The Association of Reproductive Health Professionals is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. DESIGNATION ARHP designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Nurse Practitioners and Nurses: This activity has been approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women's Health for up to 1.0 contact hour. Credit can be applied toward the nursing continuing requirements of most professional organizations and State Boards of Nursing.
Others: A certificate of attendance will be issued indicating that this activity is accredited for 1 hour of AMA PRA Category 1 CreditTM.
Sponsoring Information
This program is sponsored by the Association of Reproductive Health Professionals.
Funding Information
This project is funded through an educational grant from Teva Pharmaceuticals.
Disclosure Information
All individuals in a position to influence the content of this activity must disclose relevant financial relationship(s) with commercial interests and the nature of the relationship. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.
Target Audience
This activity is designed for physicians, nurse midwives, nurse practitioners, physician assistants, students, educators, and researchers who focus on reproductive health care, family practice or internal medicine.
Advisory Committee Disclosures
|
Suzan Goodman, MD, MPH (Planner)
Director, Teach Program Oakland, California
Dr. Goodman has no affiliations to disclose. |
Beth Kruse, MS, CNM, ARNP (Planner)
SRH & Family Planning Nurse Practitioner Seattle-King County Public Health Department Seattle, Washington
Ms. Kruse has no affiliations to disclose. |
|
Sheryl A. Kingsberg, PhD (Planner)
Clinical Psychologist University Hospitals of Cleveland University MacDonald Women’s Hospital Cleveland, OH
Dr. Kingsberg receives consulting fees from Pfizer, Shionogi, Trimel, Sprout, BioSante, NovoNordisk, and Palatin. Dr. Kingsberg has ownership interest and receives consulting fees from Viveve. |
|
ARHP Staff/Consultant Disclosures
|
Amy Swann, MA, CAE
Vice President
Nothing to disclose
Lanita L. Williams, MPH
Program Manager
Nothing to disclose |
Beth Jordan Mynett, MD
Medical Director
Nothing to disclose
Mary King, PhD
Consultant (Medical Writer)
Nothing to disclose |

Back
|